Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Yucebay F"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł :
Development and Implementation of an Oral Oncology Drug Repository Program.
Autorzy :
Stanz L; Ohio State University Wexner Medical Center, Columbus, OH.
Ulbrich T; Ohio State University College of Pharmacy, Columbus, OH.
Yucebay F; Huron Consulting.
Kennerly-Shah J; Ohio State University Wexner Medical Center, Columbus, OH.
Pokaż więcej
Źródło :
JCO oncology practice [JCO Oncol Pract] 2021 Mar; Vol. 17 (3), pp. e426-e432. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience.
Autorzy :
Yucebay F; Department of Pharmacy, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , 43210 , USA.
Matthews C; Department of Pharmacy, Roswell Park Comprehensive Cancer Center , Buffalo , New York , USA.
Puto M; Department of Pharmacy, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , 43210 , USA.
Li J; College of Pharmacy, Ohio State University , Columbus , Ohio , USA.
William B; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , USA.
Jaglowski SM; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , USA.
Penza SL; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , USA.
Vasu S; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , USA.
Benson DM; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , USA.
Andritsos LA; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , USA.
Devine SM; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , USA.
Efebera YA; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , USA.
Roddy JVF; Department of Pharmacy, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , 43210 , USA.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2019 Sep; Vol. 60 (9), pp. 2223-2229. Date of Electronic Publication: 2019 Feb 15.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Monoclonal, Humanized/*administration & dosage
Glucocorticoids/*pharmacology
Graft vs Host Disease/*drug therapy
Hematologic Neoplasms/*therapy
Hematopoietic Stem Cell Transplantation/*adverse effects
Immunosuppressive Agents/*administration & dosage
Acute Disease/mortality ; Acute Disease/therapy ; Adult ; Aged ; Allografts/drug effects ; Allografts/immunology ; Antibodies, Monoclonal, Humanized/adverse effects ; Disease Progression ; Drug Resistance ; Female ; Glucocorticoids/therapeutic use ; Graft vs Host Disease/immunology ; Graft vs Host Disease/mortality ; Graft vs Host Disease/pathology ; Hematologic Neoplasms/immunology ; Hematologic Neoplasms/mortality ; Humans ; Immunosuppressive Agents/adverse effects ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Retrospective Studies ; Transplantation, Homologous/adverse effects ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Managing Immuno-Oncology Toxicity: Top 10 Innovative Institutional Solutions.
Autorzy :
Cole S; 1 University of Texas Southwestern Medical Center, Dallas, TX.
Zibelman M; 2 Fox Chase Cancer Center, Philadelphia, PA.
Bertino E; 3 The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Yucebay F; 3 The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Reynolds K; 4 Massachusetts General Hospital, Boston, MA.
Pokaż więcej
Źródło :
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2019 Jan; Vol. 39, pp. 96-104. Date of Electronic Publication: 2019 May 17.
Typ publikacji :
Journal Article; Multicenter Study; Review
MeSH Terms :
Immunotherapy*/adverse effects
Immunotherapy*/methods
Medical Oncology*/methods
Neoplasms/*therapy
Clinical Competence ; Community Health Services ; Community-Institutional Relations ; Disease Management ; Drug Prescriptions ; Drug Resistance, Neoplasm ; Health Knowledge, Attitudes, Practice ; Humans ; Neoplasms/immunology ; Patient Education as Topic ; Physicians ; Practice Guidelines as Topic ; Practice Patterns, Nurses' ; Research ; Telemedicine
Czasopismo naukowe
Tytuł :
Use of organism identification by 16S ribosomal RNA polymerase chain reaction to shorten antimicrobial length of therapy.
Autorzy :
Gilbert EM; Northwestern Memorial Hospital, Department of Pharmacy, 251 E. Huron Street, Chicago, IL 60611, USA; Chicago State University College of Pharmacy, Department of Pharmacy Practice, 9501 S. King Drive, Chicago, IL 60628, USA.
Yucebay F; Northwestern Memorial Hospital, Department of Pharmacy, 251 E. Huron Street, Chicago, IL 60611, USA; The James Cancer Hospital at The Ohio State Wexner Medical Center, 460 W10th Ave, Columbus, OH 43210, USA.
Malczynski M; Northwestern Memorial Hospital, Clinical Microbiology Laboratory, 251 E. Huron Street, Chicago, IL 60611, USA.
Smith D; Midwestern University Chicago College of Pharmacy, Department of Pharmacy Practice, 555 31st Street, Downers Grove, IL 60515, USA; Advocate Christ Medical Center and Children's Hospital, Department of Pharmacy, 4440 95th Street, Oak Lawn, IL 60453, USA.
Esterly JS; Northwestern Memorial Hospital, Department of Pharmacy, 251 E. Huron Street, Chicago, IL 60611, USA; Chicago State University College of Pharmacy, Department of Pharmacy Practice, 9501 S. King Drive, Chicago, IL 60628, USA.
Qi C; Northwestern Memorial Hospital, Clinical Microbiology Laboratory, 251 E. Huron Street, Chicago, IL 60611, USA; Northwestern University Feinberg School of Medicine, Department of Pathology, 303 E Chicago Avenue, Chicago, IL 60611, USA.
Postelnick M; Northwestern Memorial Hospital, Department of Pharmacy, 251 E. Huron Street, Chicago, IL 60611, USA.
McLaughlin MM; Northwestern Memorial Hospital, Department of Pharmacy, 251 E. Huron Street, Chicago, IL 60611, USA; Midwestern University Chicago College of Pharmacy, Department of Pharmacy Practice, 555 31st Street, Downers Grove, IL 60515, USA. Electronic address: .
Pokaż więcej
Źródło :
Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2017 Jun; Vol. 88 (2), pp. 163-167. Date of Electronic Publication: 2017 Mar 28.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Bacterial Agents/*therapeutic use
Antimicrobial Stewardship/*methods
Bacteria/*classification
Bacteria/*genetics
Bacterial Infections/*diagnosis
Bacterial Infections/*drug therapy
RNA, Ribosomal, 16S/*genetics
Bacterial Infections/microbiology ; DNA, Bacterial/genetics ; Female ; Humans ; Male ; Middle Aged ; Polymerase Chain Reaction ; Retrospective Studies ; Sequence Analysis, DNA
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies